ZENITHDRUG — Zenith Drugs Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹676.52m
- IN₹1.22bn
- IN₹1.71bn
Annual cashflow statement for Zenith Drugs, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | R2023 March 31st | R2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 44 | 66.6 | 133 | 95.1 | 56 |
| Depreciation | |||||
| Non-Cash Items | 0 | 23.1 | 0 | -2.92 | -2.48 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -29.6 | -150 | -304 | -176 | -25.3 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 49.1 | -47.7 | -158 | -54.7 | 88.7 |
| Capital Expenditures | -26.1 | -55.7 | -53.3 | -321 | -69.9 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | 53 | 0 | 7.06 | 67.2 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Change in Net Intangibles | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -26.1 | -2.69 | -53.3 | -314 | -2.74 |
| Financing Cash Flow Items | -21.4 | -23.1 | 0.001 | 0.001 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 8.31 | 49.9 | 297 | 284 | 48.3 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 66.9 | -0.476 | 85.5 | -84.8 | -0.019 |